ABx Support is a carefully researched blend of
the non-pathogenic yeast Saccharomyces boulardii with Lactobacillus rhamnosus,
Bifidobacterium bifidum, and Bifidobacterium breve, probiotic microorganisms
documented to support the normal gastrointestinal flora during antibiotic
therapy. S. boulardii has broad, versatile gastrointestinal effects. It
stimulates numerous intestinal brush border enzymes to maintain normal
digestive functions, secretes many factors including enzymes that may reduce
dietary protein allergies following gastroenteritis and polyamines that
stimulate brush border hydrolases, proteases, and transport carriers. It
stimulates D-glucose and sodium absorption and produces short-chain fatty acids
such as butyrate and acetate that nourish colon mucosa. S. boulardii enhances
the numbers of healthful bifidobacteria in the colon while simultaneously
suppressing populations of pathogenic clostridia. L. rhamnosus is a transient
Lactobacillus that colonizes the small intestines when regularly consumed. It
favorably enhances innate and acquired immunity. It decreases T cell
proliferation, induces helper (CD4+) T cell hyporesponsiveness, increases
phagocytic activity in peripheral blood white cells and killing activity in
natural killer cells, and inhibits production of proinflammatory cytokines. L.
rhamnosus significantly augments serum and mucosal secreted antibody responses.
B. bifidum and B. breve are two species indigenous to the colon’s microflora.
Bifidobacteria are highly beneficial for normal bowel function and are
exquisitely sensitive to most antibiotics. Consumption of B. bifidum and B.
breve replenishes colonic bifidobacterial populations suppressing overgrowth by
pathogenic microbes such as Clostridium difficile and Candida albicans. B.
bifidum is among the many Bifidobacterium species normally found in large
numbers in a healthy colon microflora. B. bifidum activates B cells making them
more responsive to transforming growth factor-1 and interleukin-5 for IgA
secretion. B. bifidum enhances IgA response to C. difficile toxin A.
Supplementation with B. bifidum enhances white cell phagocytic activity. B.
breve increases the immune response of Peyer’s patch cells stimulating B cell
proliferation and antibody production. Clinical studies of the probiotic
species in ABx Support™ have shown these microorganisms support healthy
intestinal function during antibiotic-associated diarrhea, C. difficile bowel
disorders, and rotavirus diarrhea. –
Servings Per Container: 60
As a dietary supplement take 1 capsule twice daily with meals or
as directed by a physician.
Serving Size: 1 Capsule
Amount Per Serving:
Probiotic Blend ... 430mg
(10+ billion CFUs)
Saccharomyces boulardii ... 5.0+ billion CFUs
Lactobacillus rhamnosus ... 2.5+ billion CFUs
Bifidobacterium bifidum ... 1.25+ billion CFUs
Bifidobacterium breve ... 1.25+ billion CFUs
Inulin base derived from chicory
root and vegetarian capsule (hydroxypropyl methylcellulose,